Lakefront Biotherapeutics (LKFT) Shares Outstanding (2013 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Shares Outstanding (Entity) for 6 consecutive years, with $207.5 million the latest figure, recorded in Q2 2020.

• In Q2 2020, Shares Outstanding (Entity) rose 18.26% year-over-year to $207.5 million; the TTM figure through Jun 2020 stood at $207.5 million (up 18.26% YoY), while the FY2019 annual figure was $184365.0, down 99.89% from the prior year.
• Shares Outstanding (Entity) rose to $207.5 million in Q2 2020 per LKFT's latest filing, from $184365.0 in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $207.5 million in Q2 2020 and bottomed at $184365.0 in Q4 2019.
• Historically, Shares Outstanding (Entity) has averaged $147.5 million across 5 years, with a median of $156.0 million in 2017.
• Annual changes were most pronounced in 2016 — Shares Outstanding (Entity) rose 28.0% — and 2019, when it tumbled 99.89%.
• Lakefront Biotherapeutics' Shares Outstanding (Entity) stood at $146.2 million in 2016, then increased by 8.28% to $158.3 million in 2017, then climbed by 5.32% to $166.8 million in 2018, then sank by 99.89% to $184365.0 in 2019, then surged by 112431.55% to $207.5 million in 2020.
• Business Quant data shows LKFT's Shares Outstanding (Entity) at $207.5 million in Q2 2020, $184365.0 in Q4 2019, and $175.4 million in Q2 2019.